retatrutide mechanism of action retatrutide clinical trials 2024 2025 Availability & Timeline What are the mechanisms of

Focusing on whole foodslike fruits, vegetables, lean proteins, and whole grainscan significantly boost the medications benefits

Not a cure, but a new approach In a 2024 paper published in Rheumatology (Oxford), Carlucci and colleagues assessed whether GLP-1 receptor agonists triggered flares in a cohort of 18 patients with SLE

Mounjaro is approved and available in the UK

Expected timeline: NDA filing Q4 2026, FDA review in 2027, possible approval late 2027, market launch 2028

The DPP-4 enzyme breaks down active GLP-1 within 2-3 minutes of secretion, severely limiting how long the hormone can signal satiety and coordinate metabolic responses

View source Educational only